Publication: 3969

Publication: 3969

A multicenter phase II study of cabozantinib + nivolumab for patients with advanced angiosarcoma previously treated with a taxane (Alliance A091902)

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 41 (suppl 16) 11503

Meeting Instance:: ASCO 2023
Year:: 2023
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Preliminary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epreprint

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Experimental
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171; U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG);

Corr. Author:
Authors:: Juneko E. Grilley Olson Jacob Allred Scott Schuetze Andrew Poklepovic Michael J. Wagner Blake T Waechter Richard F. Riedel Meng Xu-Welliver Stephanie Berg Suzanne George Steven Robinson Paul Googe Sandra P. D'Angelo Gary Schwartz

Networks:: COLUMBIA, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NC010, LAPS-NY016, VCU

Study: Alliance-A091902
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: